Although still highly regulated, the 2018 Farm Bill legalized the cultivation, processing and distribution of industrial hemp for commercial purposes. Defined as a cannabis sativa plant containing not more than 0.3-percent THC, industrial hemp was removed from the list of Schedule 1 controlled substances and is now categorized as an agricultural commodity.

Hemp-derived cannabinoid or CBD oil is non-psychoactive and does not cause psychotropic or euphoric effects. Proponents claim it can soothe anxiety, build immunity, reduce stress, relieve pain and combat insomnia without getting consumers high.  CBD is non-psychoactive, non-toxic, and taps into the receptors in the human endocannabinoid system- a vast network of receptors that help maintain the body’s overall wellness and support many physical processes.